# Rune Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rune-labs

- Industry: Software
- Headquarters: San Francisco, US
- Website: www.runelabs.io
- Total disclosed funding: $40M
- Latest round: Series A (Nov 20, 2023)
- Investors on record: 7

## About

Based in San Francisco, Rune Labs, Inc. is a developer of innovative technology aimed at enhancing care for Parkinson's disease patients through data-driven solutions that empower both patients and clinicians.Rune Labs, Inc. was founded in 2018 in San Francisco, US, by Brian Pepin and Miro Kotzev. The company specializes in creating digital health solutions for individuals with Parkinson's disease. In November 2023, Rune Labs raised USD 12.05 mn in a funding round entirely aimed at supporting its operations. The company's total amount raised to date is also USD 12.05 mn, and it has completed 5 deals to date.Rune Labs offers StrivePD, a comprehensive care delivery ecosystem designed specifically for patients with Parkinson's disease. This platform enables users to actively manage their condition by providing clinicians with access to curated dashboards that aggregate data from diverse patient sources, facilitating informed decision-making. StrivePD also connects patients to relevant clinical trials, promoting involvement in research and potential new therapies. The primary clientele includes healthcare providers, researchers, and Parkinson's patients across North America and Europe, with aspirations to expand into other geographical markets as the platform develops.Rune Labs generates revenue through partnerships and subscription models centered around its StrivePD platform. Healthcare providers and research institutions engage with the service to access its data-driven insights, which aids in the identification and management of treatment pathways for Parkinson's disease. The transactional structure involves fees for access to the platform’s data analytics capabilities, as well as potential revenue-sharing arrangements tied to clinical trial participation. The revenue streams are supported by ongoing partnerships with life sciences organizations keen on utilizing patient data to expedite the development of therapies.Rune Labs plans to leverage its recent funding of USD 12.05 mn raised in November 2023 to enhance StrivePD's capabilities and expand into new markets. The company aims to target additional regions in Europe and North America with its platform, seeking to broaden its user base and improve treatment outcomes. Future product developments are anticipated, although specific release dates are not disclosed.

## Funding rounds

- Series A, Nov 20, 2023, $12M — TruVenturo, Moment Ventures, Eclipse Ventures, DigiTx Partners, Nexus NeuroTech Ventures
- Series A, Sep 8, 2021, $23M — Moment Ventures, Eclipse Ventures, DigiTx Partners
- Seed, Sep 28, 2020, $5M — TruVenturo, Moment Ventures, Deepwater Asset Management, DigiTx Partners, Sabbatical Ventures

## Investors

- TruVenturo (https://capitalatlas.ai/funds/truventuro) — Seed, Series A
- Moment Ventures (https://capitalatlas.ai/funds/moment-ventures) — Seed, Series A
- Deepwater Asset Management (https://capitalatlas.ai/funds/deepwater-asset-management) — Seed
- DigiTx Partners (https://capitalatlas.ai/funds/digitx-partners) — Seed, Series A
- Sabbatical Ventures (https://capitalatlas.ai/funds/sabbatical-ventures) — Seed
- Eclipse Ventures (https://capitalatlas.ai/funds/eclipse-ventures) — Series A
- Nexus NeuroTech Ventures (https://capitalatlas.ai/funds/nexus-neurotech-ventures) — Series A